{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:08:48Z","timestamp":1791554928666,"version":"4.3.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":2050,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1038\/modpathol.2017.6","type":"journal-article","created":{"date-parts":[[2017,3,10]],"date-time":"2017-03-10T07:41:43Z","timestamp":1489131703000},"page":"826-833","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":111,"title":["Expression of PD-1 and PD-L1 in thymic epithelial neoplasms"],"prefix":"10.1016","volume":"30","author":[{"given":"Annikka","family":"Weissferdt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Kalhor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Bassett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio I","family":"Wistuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar A","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2017.6_bib1","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ijc.11099","article-title":"Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies","volume":"105","author":"Engels","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.2017.6_bib2","doi-asserted-by":"crossref","first-page":"S260","DOI":"10.1097\/JTO.0b013e3181f1f62d","article-title":"Epidemiology of thymoma and associated malignancies","volume":"5","author":"Engels","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1038\/modpathol.2017.6_bib3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.lungcan.2012.08.002","article-title":"Molecular aspects of thymic carcinoma","volume":"78","author":"Weissferdt","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1038\/modpathol.2017.6_bib4","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/modpathol.2017.6_bib5","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2017.6_bib6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/nrd3806","article-title":"Cancer: PD1 makes waves in anticancer immunotherapy","volume":"11","author":"Flemming","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1038\/modpathol.2017.6_bib7","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1158\/1078-0432.CCR-13-0855","article-title":"PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies","volume":"19","author":"Chen","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2017.6_bib8","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.ejca.2014.01.018","article-title":"Programmed cell death-ligand 1 expression in surgically resected stage I pulmonary adenocarcinoma and its correlation with driver mutations and clinical outcomes","volume":"50","author":"Yang","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1038\/modpathol.2017.6_bib9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.5414\/NP300698","article-title":"PD1 (CD279) and PD-L1 (CD274, B7H1) expression in primary central nervous system lymphomas (PCNSL)","volume":"33","author":"Berghoff","year":"2014","journal-title":"Clin Neuropathol"},{"key":"10.1038\/modpathol.2017.6_bib10","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2147\/OTT.S59959","article-title":"Protein expression of programmed death 1 ligand 1 and ligand 2 independently predict poor prognosis in surgically resected lung adenocarcinoma","volume":"7","author":"Zhang","year":"2014","journal-title":"Onco Targets Ther"},{"key":"10.1038\/modpathol.2017.6_bib11","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.critrevonc.2013.08.002","article-title":"Targeting the PD1\/PD-L1 axis in melanoma: biological rationale, clinical challenges and opportunities","volume":"89","author":"Merelli","year":"2014","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1038\/modpathol.2017.6_bib12","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/ajcp\/111.6.826","article-title":"Thymoma, atypical thymoma, and thymic carcinoma. A novel conceptual approach to the classification of thymic epithelial neoplasms","volume":"111","author":"Suster","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2017.6_bib13","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1309\/AJCP36ALGUZWOSEA","article-title":"Thymomas II: a clinicopathologic correlation of 250 cases with a proposed staging system with emphasis on pathologic assessment","volume":"137","author":"Moran","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2017.6_bib14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1309\/AJCPLF3XAT0OHADV","article-title":"Thymic carcinoma, part 2: a clinicopathologic correlation of 33 cases with a proposed staging system","volume":"138","author":"Weissferdt","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2017.6_bib15","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"10.1038\/modpathol.2017.6_bib16","doi-asserted-by":"crossref","first-page":"6738","DOI":"10.4049\/jimmunol.181.10.6738","article-title":"The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands","volume":"181","author":"Kinter","year":"2008","journal-title":"J Immunol"},{"key":"10.1038\/modpathol.2017.6_bib17","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm730","article-title":"Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion","volume":"8","author":"Dong","year":"2002","journal-title":"Nat Med"},{"key":"10.1038\/modpathol.2017.6_bib18","first-page":"3167","article-title":"Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates","volume":"28","author":"Brahmer","year":"2010","journal-title":"Clin Oncol"},{"key":"10.1038\/modpathol.2017.6_bib19","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/JTO.0000000000000429","article-title":"Diffuse high intensity PD-L1 staining in thymic epithelial tumors","volume":"10","author":"Padda","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1038\/modpathol.2017.6_bib20","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.lungcan.2015.03.003","article-title":"Immunohistochemical status of PD-L1 in thymoma and thymic carcinoma","volume":"88","author":"Katsuya","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1038\/modpathol.2017.6_bib21","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.athoracsur.2015.10.044","article-title":"Clinicopathologic and prognostic implications of programmed death ligand 1 expression in thymoma","volume":"101","author":"Yokoyama","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"10.1038\/modpathol.2017.6_bib22","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1158\/1078-0432.CCR-16-0434","article-title":"Prognostic value of programmed death ligand 1 and programmed death 1 expression in thymic carcinoma","volume":"22","author":"Yokoyama","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2017.6_bib23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejca.2016.06.015","article-title":"PD-L1 is upregulated by radiochemotherapy in rectal adenocarcinoma patients and associated with a favourable prognosis","volume":"65","author":"Hecht","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1038\/modpathol.2017.6_bib24","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1158\/1078-0432.CCR-13-3271","article-title":"Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy","volume":"20","author":"Taube","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2017.6_bib25","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1158\/1078-0432.CCR-04-0428","article-title":"B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression","volume":"10","author":"Konishi","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2017.6_bib26","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00262-012-1231-7","article-title":"Tumor-infiltrating lymphocytes predict response to chemotherapy in patients with advance non-small cell lung cancer","volume":"61","author":"Liu","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"10.1038\/modpathol.2017.6_bib27","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1073\/pnas.0611533104","article-title":"Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer","volume":"104","author":"Hamanishi","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2017.6_bib28","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1158\/1078-0432.CCR-08-0133","article-title":"Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer","volume":"14","author":"Al-Shibli","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2017.6_bib29","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1158\/0008-5472.CAN-12-2606","article-title":"PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer","volume":"73","author":"Badoual","year":"2013","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2017.6_bib30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12943-016-0539-x","article-title":"Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer","volume":"15","author":"Li","year":"2016","journal-title":"Mol Cancer"},{"key":"10.1038\/modpathol.2017.6_bib31","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/ijc.26272","article-title":"PD-1 expression on Melan-A-reactive T cells increases during progression to metastatic disease","volume":"130","author":"Kr\u00f6nig","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.2017.6_bib32","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.jaad.2014.01.880","article-title":"Expression of programmed death receptor ligand 1 in melanoma may indicate tumor progression and poor patient survival","volume":"70","author":"Oba","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/modpathol.2017.6_bib33","doi-asserted-by":"crossref","first-page":"709s","DOI":"10.1158\/1078-0432.CCR-06-1868","article-title":"Implications of B7-H1 expression in clear cell carcinoma of the kidney for prognostication and therapy","volume":"13","author":"Thompson","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2017.6_bib34","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.ejca.2013.02.015","article-title":"Clinical impact of programmed cell death ligand 1 expression in colorectal cancer","volume":"49","author":"Droeser","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1038\/modpathol.2017.6_bib35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ygyno.2016.03.008","article-title":"PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer","volume":"141","author":"Webb","year":"2016","journal-title":"Gynecol Oncol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol20176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol20176","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222011784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222011784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/modpathol.2017.6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol20176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:45:29Z","timestamp":1760229929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222011784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0893395222011784"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2017.6","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of PD-1 and PD-L1 in thymic epithelial neoplasms","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2017.6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}